NOV241220P21000
- 0.00
- 0.000.00%
NOV Inc Newsroom
Stifel Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $24
Barclays Maintains NOV Inc(NOV.US) With Sell Rating, Maintains Target Price $12
Piper Sandler Initiates NOV Inc(NOV.US) With Hold Rating, Announces Target Price $17
Barclays Maintains NOV Inc(NOV.US) With Sell Rating, Cuts Target Price to $12
NOV Is Maintained at Underweight by Barclays
Express News | Nov Inc : Barclays Cuts Target Price to $12 From $16
Wells Fargo Reaffirms Their Sell Rating on NOV (NOV)
Worst Performing Stocks for Tax Loss Selling – Wolfe
NOV Appoints Chris Kendall to the Board of Directors
Express News | Nov Appoints Chris Kendall to the Board of Directors
BMO Capital Initiates NOV Inc(NOV.US) With Hold Rating, Announces Target Price $18
Patterson-UTI Raised, Weatherford Cut at Goldman With Focus on Capital Returns
16 Analysts Have This To Say About NOV
NOV Analyst Ratings
Express News | Nov Inc : Atb Capital Markets Cuts to Sector Perform From Outperform; Cuts Target Price to $19 From $22
ATB Capital Markets Initiates NOV Inc(NOV.US) With Hold Rating, Announces Target Price $19
Express News | Nov Inc : Citigroup Cuts Target Price to $17 From $18
Citi Maintains NOV Inc(NOV.US) With Hold Rating, Cuts Target Price to $17
NOV (NYSE:NOV) Shareholders Will Want The ROCE Trajectory To Continue
NOV Inc.'s (NYSE:NOV) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?